Advertisement

Topics

Vaccination to improve the persistence of CD19 CAR T cells in relapsed ALL

09:07 EDT 23 Sep 2016 | ecancermedicalscience

Dr Ghorashian speaks with ecancertv at Childhood Cancer 2016 about results from a European trial of CD19 CAR T cells to treat relapsed ALL. She describes the creation, transduction and activation of the T cell line, and that vaccination of patients did...

Original Article: Vaccination to improve the persistence of CD19 CAR T cells in relapsed ALL

NEXT ARTICLE

More From BioPortfolio on "Vaccination to improve the persistence of CD19 CAR T cells in relapsed ALL"

Quick Search
Advertisement
 

Relevant Topics

Pediatrics
Pediatrics is the general medicine of childhood. Because of the developmental processes (psychological and physical) of childhood, the involvement of parents, and the social management of conditions at home and at school, pediatrics is a specialty. With ...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...